Vidarabine
Antiviral medication
| Vidarabine | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Vidarabine, also known as adenine arabinoside or ara-A, is an antiviral drug that was one of the first antiviral agents to be developed and used in clinical practice. It is primarily used for the treatment of herpes simplex virus (HSV) infections, particularly in cases of herpes simplex encephalitis and herpes zoster in immunocompromised patients.
History[edit | edit source]
Vidarabine was first synthesized in the 1960s and was initially investigated for its potential as an anticancer agent. However, its antiviral properties were soon recognized, leading to its development as an antiviral medication. It was approved for medical use in the United States in 1976.
Mechanism of Action[edit | edit source]
Vidarabine works by inhibiting viral DNA polymerase, an enzyme critical for viral DNA replication. It is a nucleoside analog, meaning it mimics the natural nucleosides that are the building blocks of DNA. Once incorporated into viral DNA, vidarabine causes premature chain termination, effectively halting viral replication.
Pharmacokinetics[edit | edit source]
Vidarabine is administered intravenously due to its poor oral bioavailability. It is rapidly deaminated to arabinosyl hypoxanthine, which is less active. The drug is primarily excreted by the kidneys.
Clinical Uses[edit | edit source]
Vidarabine is used in the treatment of severe HSV infections, including:
- Herpes simplex encephalitis
- Neonatal herpes simplex
- Herpes zoster in immunocompromised patients
Side Effects[edit | edit source]
Common side effects of vidarabine include nausea, vomiting, diarrhea, and headache. More serious side effects can include neurotoxicity and bone marrow suppression.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
